ENTRY       D09728                      Drug
NAME        Bosutinib hydrate (JAN);
            Bosutinib monohydrate;
            Bosulif (TN)
PRODUCT     BOSULIF (Pfizer Laboratories Div Pfizer)
            BOSULIF (U.S. Pharmaceuticals)
FORMULA     C26H29Cl2N5O3. H2O
EXACT_MASS  547.1753
MOL_WEIGHT  548.4614
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG03161  BCR-ABL inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01EA04
            Chemical structure group: DG00718
            Product (DG00718): D09728<JP/US>
EFFICACY    Antineoplastic, Tyrosine kinase inhibitor
  DISEASE   Chronic myeloid leukemia (Philadelphia chromosome positive) [DS:H00004]
TARGET      BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]
            SRC [HSA:6714] [KO:K05704]
  PATHWAY   hsa04012(25+6714)  ErbB signaling pathway
            hsa05200(25)  Pathways in cancer
            hsa05220(25)  Chronic myeloid leukemia
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07045  Antineoplastics - protein kinase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EA BCR-ABL tyrosine kinase inhibitors
                 L01EA04 Bosutinib
                  D09728  Bosutinib hydrate (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Bosutinib
                D09728  Bosutinib hydrate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D09728  Bosutinib hydrate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG00718  Bosutinib
                 D09728  Bosutinib hydrate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00718  Bosutinib
                 D09728  Bosutinib hydrate
            Drug classes [BR:br08332]
             Antineoplastic
              DG03161  BCR-ABL inhibitor
               D09728  Bosutinib hydrate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Non-receptor tyrosine kinases
               SRC family
                SRC
                 D09728  Bosutinib hydrate (JAN) &lt;JP/US&gt;
               ABL family
                BCR-ABL [HSA_VAR:25v1]
                 D09728  Bosutinib hydrate (JAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09728
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09728
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09728
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09728
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09728
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D09728
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG03161  BCR-ABL inhibitor
                DG00718  Bosutinib
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00718  Bosutinib
DBLINKS     PubChem: 124490468
            ChEBI: 68533
            LigandBox: D09728
ATOM        37
            1   C8x C    19.0400  -18.3400
            2   C8y C    19.0400  -19.7400
            3   C8y C    20.2300  -20.4400
            4   C8y C    21.4900  -19.7400
            5   C8y C    21.4900  -18.3400
            6   N5x N    20.2300  -17.6400
            7   C8x C    22.6800  -20.4400
            8   C8y C    23.8700  -19.7400
            9   C8y C    23.8700  -18.3400
            10  C8x C    22.6800  -17.6400
            11  N1b N    20.2300  -21.8400
            12  O2a O    25.1300  -17.6400
            13  C1b C    26.3200  -18.3400
            14  C8y C    21.4900  -22.5400
            15  C8y C    21.4900  -23.9400
            16  C8x C    22.6800  -24.6400
            17  C8y C    23.8700  -23.9400
            18  C8y C    23.8700  -22.5400
            19  C8x C    22.6800  -21.8400
            20  X   Cl   25.1300  -24.6400
            21  C1b C    27.5100  -17.7100
            22  C1b C    28.7000  -18.4100
            23  N1y N    29.8900  -17.7100
            24  C1x C    31.0800  -18.4100
            25  C1x C    32.3400  -17.7100
            26  N1y N    32.3400  -16.3100
            27  C1x C    31.1500  -15.6100
            28  C1x C    29.8900  -16.3100
            29  O2a O    25.1300  -20.5100
            30  C1a C    26.3200  -19.8100
            31  X   Cl   20.3000  -24.6400
            32  O2a O    25.1300  -21.8400
            33  C1a C    26.3200  -22.6100
            34  C3b C    17.7800  -20.5100
            35  N3a N    16.5900  -21.2100
            36  C1a C    33.5300  -15.6100
            37  O0  O    32.6200  -22.6100
BOND        39
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 2
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11    5  10 2
            12    3  11 1
            13    9  12 1
            14   12  13 1
            15   11  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   14  19 1
            22   17  20 1
            23   13  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 1
            27   24  25 1
            28   25  26 1
            29   26  27 1
            30   27  28 1
            31   23  28 1
            32    8  29 1
            33   29  30 1
            34   15  31 1
            35   18  32 1
            36   32  33 1
            37    2  34 1
            38   34  35 3
            39   26  36 1
///
